Clinical trials: Stimulant Use Disorder
HIV/AIDS, Stimulant Use Disorders
RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users
In the era of HIV treatment as prevention (TasP), efforts are needed to identify evidence-based combination prevention approaches that achieve greater decreases HIV viral load among populations that are more likely to engage in…
- Trial name
- ARTEMIS (NCT01926184)
- Testing
- Affect Regulation Treatment to Enhance Meth Intervention Success (ARTEMIS), Contingency Management (CM)
- Where
- United States
- Volunteers
- 110 people
- Sponsor
- University of California, San Francisco
Stimulant Use & Co-occuring Opioid Use Disorders
Stimulant Oxytocin Study
This study will investigate the effects of intranasal administration of oxytocin, a social neuropeptide, on reducing stimulant use, enhancing therapeutic engagement, and susceptibility to stress-induced relapse in Veterans with…
- Trial name
- SOS (NCT03016598)
- Testing
- Intranasal oxytocin
- Where
- 3 sites in United States
- Volunteers
- 42 people
- Sponsor
- VA Office of Research and Development
Stimulants Use Disorder
Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use Disorder
The current study will investigate whether add-on dextromethorphan (DM) and memantine (MM) is able to improve the treatment outcomes for ATSUD, and be associated with improvement in inflammatory markers, neurotrophic factors and…
- Trial name
- NCT03729128
- Testing
- dextromethorphan and memantine (DM+MM)
- Where
- Taiwan
- Volunteers
- 85 people
- Sponsor
- Tzu-Yun Wang